Community observations, not medical advice.Always speak with a qualified healthcare professional.
botanical × Neurological

Cannabis (THC) for Spasticity (MS)

Delta-9-tetrahydrocannabinol, the primary psychoactive cannabinoid in Cannabis sativa, acting as a partial agonist at CB1 receptors; used medically for chronic pain, chemotherapy-induced nausea, appetite stimulation, and spasticity. Subject to legal restrictions varying by jurisdiction.

-published research: study records
-published research: findings
Not formally gradedcertainty of the research
On this pageOverviewEvidenceCommunity outcomesRelated
Why Cannabis (THC) for Spasticity (MS)?

The connection

Muscle stiffness and spasms, commonly in multiple sclerosis. NHS-prescribed cannabis-based medicines are licensed for MS spasticity.

Also known as: THC, Delta-9-tetrahydrocannabinol, Marijuana, Cannabis sativa

Published research

Cannabis (THC) × Spasticity (MS): at a glance

Every published result for this pair, extracted and audited.

Published research

Cannabis (THC) / Spasticity (MS): publication years

What this means: Counts describe research quantity, not treatment effectiveness or certainty.

Cannabis (THC) / Spasticity (MS): publication years (publications, count)
CategoryPublications (count)
20232
20242
20262
← Zoom out: all evidence for Cannabis (THC)Zoom out: compare compounds for Spasticity (MS) →
Published research

Cannabis (THC) × Spasticity (MS): the evidence base

Hand-selected PubMed studies, linked to the originals.

6studies referenced
6journals
2023–2026publication range

Ordered by strength of evidence, then result direction.

01Cannabis-Based Products for Chronic Pain : An Updated Systematic ReviewChou R, et al. · Annals of internal medicine · 2026PMID 41429020 ↗02The effects of oral cannabidiol supplementation on blood pressure in adults: a systematic review of randomised controlled trialsRoberts A, et al. · Journal of cannabis research · 2026PMID 42321899 ↗03Effectiveness of Cannabidiol to Manage Chronic Pain: A Systematic ReviewMohammed SYM, et al. · Pain management nursing : official journal of the American Society of Pain Management Nurses · 2024PMID 37953193 ↗04Cannabis and Cannabinoids in Adults With Cancer: ASCO GuidelineBraun IM, et al. · Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024PMID 38478773 ↗05Evidence-Based Treatment of Pain in Chemotherapy-Induced Peripheral NeuropathyD'Souza RS, et al. · Current pain and headache reports · 2023PMID 37058254 ↗06Cannabis-based medicines and medical cannabis for adults with cancer painHäuser W, et al. · The Cochrane database of systematic reviews · 2023PMID 37283486 ↗
Search PubMed ↗View on PubChem ↗Find clinical trials ↗

Community experiences

Contributors volunteered; this does not establish treatment effectiveness or population incidence.

Reported changes

No publishable community breakdown is available. This does not establish that no reports exist.

Share your experience
Important: This page reflects observational, aggregate-only community reporting and independent published research. It is not medical advice, and it does not claim any compound treats, cures, or is effective for any condition. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or treatment.